Aviva has seen a 1% increase in protection sales in the first half of 2026, according to its half-year statistics.
The provider quantified this growth using the annual premium equivalent (APE) for protection sales. Total sales across protection and health in H1 2026 reached £86m, at a steady level year-on-year compared to 2025. Individual protection saw a slight downturn in new business APE, from £91m in the first six months of 2025, to £87m in the same period in 2026, a 4% decrease. Growth in the product line was mostly attributed to the provider's group protection offering, up to £86m in new business APE from £81m in the first half of 2025, a 6% uptick. Health saw the most dramatic downtu...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.





